Norris Medicines Ltd
₹15.25
-0.56 (3.54%)
Fri, 23 Oct 2026, 02:52 am
Health Technology
Pharmaceuticals: Major
24.5KNorris Medicines Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 34.01 | 34.01 | 34.00 | 34.00 | 34.00 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Public | 65.92 | 65.92 | 65.93 | 65.93 | 65.93 |
| Government | 0 | 0 | 0 | 0 | 0 |
Norris Medicines Ltd Shareholding Pattern
The Norris Medicines Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Norris Medicines Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Norris Medicines Ltd (NSE: , BSE: 524414) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Norris Medicines Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Norris Medicines Ltd Shareholding Pattern (Latest)
The latest Norris Medicines Ltd shareholding for Jun 2026 is:
- Promoters: 34.01%
- FII: 0%
- DII: 0.07%
- Public: 65.92%
- Government: 0%
Promoter holding in Norris Medicines Ltd remains stable, reflecting consistent long-term commitment.
Norris Medicines Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Norris Medicines Ltd.
- Jun 2026: 34.01%
- Mar 2026: 34.01%
- Dec 2025: 34.00%
- Sept 2025: 34.00%
- Jun 2025: 34.00%
Promoter stake remains largely stable, showing consistent ownership structure.
Norris Medicines Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Norris Medicines Ltd.
- Jun 2026: 0%
- Mar 2026: 0%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Norris Medicines Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Jun 2026: 0.07%
- Mar 2026: 0.07%
- Dec 2025: 0.07%
- Sept 2025: 0.07%
- Jun 2025: 0.07%
DII holdings remain stable, reflecting steady institutional participation.
Norris Medicines Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Jun 2026: 65.92%
- Mar 2026: 65.92%
- Dec 2025: 65.93%
- Sept 2025: 65.93%
- Jun 2025: 65.93%
Public holding remains stable with consistent retail participation.
Norris Medicines Ltd Government Holding
Government holding in Norris Medicines Ltd currently stands at 0%.
Norris Medicines Ltd operates without significant government ownership.
Norris Medicines Ltd Shareholding Analysis Summary
The Norris Medicines Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Norris Medicines Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Norris Medicines Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
